This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9301554

PUBLISHED SUBJECT

PQ/645/2022 PEMETREXED 500MG INJ

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Lisboa, Lisboa; Portugal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491
Bidder
Ciclum Pharma, Lda. · Tax ID 504362674
Bidder
SANDOZ FARMACEUTICA, LDA · Tax ID 506985261
Bidder
LILLY PORTUGAL-PROD.FARMAC.LDA · Tax ID 500165602
Bidder
ACCORD HEALTHCARE, UNIPESSOAL, LDA · Tax ID 508622263
Bidder
FRESENIUS KABI PHARMA PORTUGAL · Tax ID 504293753

HOW MUCH AND WHEN

Values and timeline

Contract price
€4,928.00
Procedure base price
€93,753.66
Total effective price
Not reported on Portal BASE
Publication date
7 June 2022
Award date
21 February 2022
Signing date
21 February 2022
Performance period
334 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
5777853

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts